Evidence map›Paper›PMID 23733189›Full record

ArticleThe Journal of biological chemistry2013

Signal transducer and activator of transcription 3 (STAT3) degradation by proteasome controls a developmental switch in neurotrophin dependence.

Sachiko Murase

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sachiko MuraseLaboratory of Molecular Biology, NINDS, National Institutes of Health, Bethesda, Maryland 20892, USA. sachikom@ninds.nih.gov
National Institutes of Health · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Neonatal brains develop through a program that eliminates about half of the neurons. During this period, neurons depend on neurotrophins for their survival. Recently, we reported that, at the conclusion of the naturally occurring death period, neurons become neurotrophin-independent and, further, that this developmental switch is achieved by the emergence of a second survival pathway mediated by signal transducer and activator of transcription 3 (STAT3). Here I show that calcineurin plays a key role in controlling the developmental switch in mouse hippocampal neurons. Calcineurin promotes the degradation of STAT3 via the ubiquitin-proteasome pathway. Inhibition of calcineurin acutely increases total levels of STAT3 as well as its activated forms, resulting in decreased levels of the tumor suppressor p53 and its proapoptotic target, Bax. In vivo and in vitro, calcineurin regulates levels of STAT3 and neurotrophin dependence. TMF/ARA 160 (TATA element modulatory factor/androgen receptor co-activator 160), the key mediator of STAT3 ubiquitination, is required for calcineurin-dependent STAT3 degradation. Thus, these results show that the ubiquitin-proteasome pathway controls the critical developmental switch of neurotrophin dependence in the newborn hippocampus.

Indexed as

AnimalsAnimals, Newbornbcl-2-Associated X ProteinBlotting, WesternCalcineurinCells, CulturedDNA-Binding ProteinsFemaleGolgi Matrix ProteinsHippocampusImmunohistochemistryMaleMiceMice, Inbred C57BLNerve Growth FactorsNeuronsBax protein, mousebcl-2-Associated X ProteinCalcineurinDNA-Binding ProteinsGolgi Matrix ProteinsNerve Growth FactorsProteasome Endopeptidase ComplexStat3 protein, mouseSTAT3 Transcription FactorTacrolimusTmf1 protein, mouseTranscription FactorsTumor Suppressor Protein p53Ubiquitin-Protein LigasesVesicular Transport ProteinsBaxCalcineurinDevelopmental DeathNeurotrophinsp53STAT3Ubiquitin-Proteasome Pathway

Identifiers

PMID23733189
PMCPMC3711283
OpenAlexW1977981949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.